Security key
81728J109
Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS)
CUSIP: 81728J109
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 449,769
- Total 13F value
- $1,358,304
- Share change
- +2,130
- SEC-reported price per share
- $3.02
- Number of holders
- 7
- Value change
- +$6,433
- Number of buys
- 2
- Number of sells
- 1
- Shares outstanding
- 16,385,263
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
7
Top holders
7
SRTS full security history
Ownership snapshot
Full 13F holder table
Sensus Healthcare, Inc. SEC filings
Sensus Healthcare, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 81728J109
Recent filing periods:
Ownership snapshot
Top reported holders of SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Edwin L. Solot Jr.
Disclosed value leader
Edwin L. Solot Jr.
Comparable rows
15/15
Latest evidence
12 May 2026
13D/G
3/4/5
13F
Lead comparable stake: 7.6%
13D/G row: Edwin L. Solot Jr.
Showing 1-6 of 15 holder rows.
Quick read
Edwin L. Solot Jr. leads the comparable SEC ownership view at 7.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Edwin L. Solot Jr.'s linked filing trail.
Comparable ownership
Top 5
Edwin L. Solot Jr.
7.6%
Joseph C. Sardano
7.1%
Michael Sardano
0.98%
Eric Sachetta
0.89%
Magdalena Martinez
0.07%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Edwin L. Solot Jr. |
13D/G
|
7.6%
|
$5,827,910
1,245,280 shares
|
$0 | 31 Dec 2024 |
| Joseph C. Sardano |
3/4/5
13D/G
CHIEF EXECUTIVE OFFICER, Director
|
7.1%
from 13D/G
|
$4,837,180
1,200,293 shares
|
+$100,750 | 18 Nov 2025 |
| Michael Sardano |
3/4/5
PRESIDENT AND GENERAL COUNSEL, Director
|
0.98%
|
$645,749
159,839 shares
|
+$11,916 | 12 Dec 2025 |
| Eric Sachetta |
3/4/5
Director
|
0.89%
|
$487,279
145,706 shares
|
+$40,133 | 12 May 2026 |
| Magdalena Martinez |
3/4/5
CHIEF OPERATING OFFICER
|
0.07%
|
$47,090
12,013 shares
|
— | 19 Dec 2023 |
| Pacific Ridge Capital Partners, LLC |
13F
Company
|
4.9%
|
$3,168,367
796,072 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
449,769
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
40
Q2 2026 holders
7
Holder diff
-33
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend